MENDRA
LIVE

Serial Number

99658639

Owner

Mendra, Inc.

Attorney

Mark A. Jansen

Filing Date

Feb 18, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MENDRA Trademark

Serial Number: 99658639

MENDRA is a trademark filed by Mendra, Inc. on February 18, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Mendra, Inc.

4 Embarcadero Center, Suite 3110
San Francisco, CA 94111

Entity Type: 03

Trademark Details

Filing Date

February 18, 2026

Registration Date

Not Registered

Goods & Services

downloadable artificial intelligence software for use with rare diseases; downloadable artificial intelligence software for use in the field of medicine and medical research; downloadable artificial intelligence (AI) software for use in pharmaceutical research, drug discovery, clinical development, regulatory analysis, data analysis, and commercialization; downloadable software for collecting, analyzing, searching, and managing biomedical, clinical, and scientific data; downloadable software platforms for identifying, evaluating, and developing pharmaceutical and therapeutic assets, including software for rare disease research; downloadable software for identifying and recruiting clinical trial participants; downloadable software for managing global regulatory submissions and market access data; downloadable software for mapping and forecasting rare disease populations; downloadable software for facilitating real-time collaboration in pharmaceutical development and commercialization; downloadable artificial intelligence software for developing treatments and drugs for treating rare diseases

Pharmaceutical preparations and substances; therapeutic and prophylactic pharmaceutical products; medicines for the treatment and prevention of rare diseases, autoimmune diseases, inflammatory diseases, and infectious diseases and disorders; pharmaceutical products for use in medical research and clinical development; pharmaceutical products in development for regulatory approval

Scientific research and development services in the fields of pharmaceuticals, therapeutics, and medicine; research and development of pharmaceutical products, therapies, and treatments; biomedical research services; pharmaceutical research and clinical development services; providing online non-downloadable software artificial intelligence software for use with rare diseases; providing online non-downloadable software artificial intelligence software for use in the field of medicine and medical research; providing online non-downloadable software artificial intelligence (AI) software for use in pharmaceutical research, drug discovery, clinical development, regulatory analysis, data analysis, and commercialization; providing online non-downloadable software for collecting, analyzing, searching, and managing biomedical, clinical, and scientific data; providing online non-downloadable software for identifying, evaluating, and developing pharmaceutical and therapeutic assets, including software for rare disease research; providing non-downloadable artificial intelligence software for use in pharmaceutical research, rare disease analysis, asset evaluation, clinical development, and commercialization; providing online non-downloadable software for searching, aggregating, analyzing, and modeling biomedical, clinical, and pharmaceutical data; providing temporary use of online, non-downloadable software for identifying and recruiting clinical trial participants; providing temporary use of online, non-downloadable software for managing global regulatory submissions and market access data; providing temporary use of online, non-downloadable software for mapping and forecasting rare disease populations; providing temporary use of online, non-downloadable software for facilitating real-time collaboration in pharmaceutical development and commercialization; providing temporary use of online, non-downloadable artificial intelligence software for developing treatments and drugs for treating rare diseases

Medical research and development services; providing medical and scientific information in the field of rare diseases; providing health and medical information relating to diseases, disorders, diagnosis, treatment, and prevention; medical advisory services relating to pharmaceutical research and development; Consulting services in the field of rare disease drug development; Prevention, diagnostics, treatment, and therapy for rare diseases

Filing History

APPLICATION FILING RECEIPT MAILED
Feb 18, 2026 MAFR
NEW APPLICATION ENTERED
Feb 18, 2026 NWAP